Clinical Trial Update: Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 [Phase 3]

View source ↗

Summary

A Phase 3 extension study evaluating long-term treatment with voxelotor in participants who completed the prior study in sickle cell disease was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Oxbryta (voxelotor)

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-11-18